{
    "clinical_trials": [
      {
        "trial_id": 3001,
        "trial_name": "Diabetes Medication Efficacy",
        "phase": "Phase 3",
        "start_date": "2022-01-15",
        "end_date": "2023-12-15",
        "participants_enrolled": 150,
        "status": "Ongoing",
        "primary_outcome": "Reduction in HbA1c levels",
        "principal_investigator": "Dr. Emily Clark"
      },
      {
        "trial_id": 3002,
        "trial_name": "Asthma Treatment in Adolescents",
        "phase": "Phase 2",
        "start_date": "2021-06-01",
        "end_date": "2023-11-30",
        "participants_enrolled": 80,
        "status": "Completed",
        "primary_outcome": "Improvement in lung function",
        "principal_investigator": "Dr. Michael Jones"
      },
      {
        "trial_id": 3003,
        "trial_name": "Cholesterol-Lowering Drug",
        "phase": "Phase 4",
        "start_date": "2020-09-01",
        "end_date": "2023-09-01",
        "participants_enrolled": 200,
        "status": "Completed",
        "primary_outcome": "Decrease in LDL cholesterol",
        "principal_investigator": "Dr. Robert Lee"
      },
      {
        "trial_id": 3004,
        "trial_name": "Cancer Immunotherapy Study",
        "phase": "Phase 1",
        "start_date": "2023-01-01",
        "end_date": "2025-12-31",
        "participants_enrolled": 50,
        "status": "Ongoing",
        "primary_outcome": "Tumor size reduction",
        "principal_investigator": "Dr. Sarah Green"
      },
      {
        "trial_id": 3005,
        "trial_name": "Hypertension Management in Elderly",
        "phase": "Phase 2",
        "start_date": "2022-03-01",
        "end_date": "2024-03-01",
        "participants_enrolled": 120,
        "status": "Ongoing",
        "primary_outcome": "Blood pressure control",
        "principal_investigator": "Dr. Emily Clark"
      }
    ]
  }
  